Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia

Published:2019-06-24 Issue:9 Volume:36 Page:
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Chen Kent T. J.,Gilabert-Oriol Roger,Bally Marcel B.,Leung Ada W. Y.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s11095-019-2654-z.pdf

Reference196 articles.

1. Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006 Nov 25;368(9550):1894–907.

2. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999 Sep 30;341(14):1051–62.

3. Szotkowski T, Rohon P, Zapletalova L, Sicova K, Hubacek J, Indrak K. Secondary acute myeloid leukemia - a single center experience. Neoplasma. 2010 2010;57(2):170–8. eng.

4. Larson RA. Therapy-related myeloid neoplasms. Haematologica. 2009;94(4):454–9.

5. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016 Jul 1 6(7):e441. Pubmed Central PMCID: 5030376.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Nanoparticles for Skin Protection — A Review;Nano LIFE;2024-08-09

2. Recent Advances in Material Technology for Leukemia Treatments;Advanced Materials;2024-04-12

3. Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax;Pharmaceutics;2024-01-31

4. Advantages of nanomedicine over the conventional treatment in Acute myeloid leukemia;Journal of Biomaterials Science, Polymer Edition;2023-12-19

5. Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia;Blood Cancer Journal;2023-12-18